Dunn Medicine
About:
Dunn Medicine is a clinical precision medication guidance service provider.
Website: https://www.dunen.net/index.html
Top Investors: CICC, Jingyao Fund
Description:
Dunn Medicine is a clinical precision medication guidance service provider. The company mainly focuses on rational drug use. To this end, it focuses on building molecular platforms and mass spectrometry platforms. Its molecular platforms include fluorescence quantitative PCR instruments, illumina second-generation sequencers, and ABI first-generation sequencers.
Total Funding Amount:
100M CNY
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2017-01-01
Contact Email:
postmaster(AT)dunen.net
Founders:
Number of Employees:
51-100
Last Funding Date:
2024-02-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai